The Future of Healthcare Technology with Eli Lilly and Company's Diogo Rau
2025/2/6
Revisionist History
D
Diogo Rau
@Diogo Rau : 我在科技行业工作多年,深感医药行业在消费者体验方面有待提升。医药行业自20世纪50年代以来变化甚微,患者获取药物的流程繁琐。我希望将科技融入医药行业的各个环节,从药物发现到患者服务,实现以患者为中心的革新。我设想未来患者能够当天获得所需药物,并利用可穿戴设备等工具持续参与治疗过程。此外,我也对人工智能在药物发现中的应用充满期待,相信未来会出现人类无法想象的创新药物。我认为,数据应属于患者,而非仅限于医疗保健提供者。通过提高药物治疗的“swiftness”,即快速获得药物并看到效果,可以显著改善患者的依从性。
Deep Dive
Diogo Rau, Chief Information and Digital Officer at Eli Lilly and Company, discusses his unique background and the surprising aspects of transitioning from the tech industry to a life sciences company. He highlights the significant difference in timescales and the long-term perspective prevalent in the pharmaceutical industry.
- Diogo Rau's transition from Apple to Eli Lilly
- Long timescales in pharmaceutical industry vs. tech
- Long-term perspective in decision-making at Eli Lilly